Kanda, Junya http://orcid.org/0000-0002-6704-3633
Hayashi, Hiromi
Ruggeri, Annalisa
Kimura, Fumihiko
Volt, Fernanda
Takahashi, Satoshi
Labopin, Myriam
Kako, Shinichi
Tozatto-Maio, Karina
Yano, Shingo
Sanz, Guillermo http://orcid.org/0000-0002-2767-8191
Uchida, Naoyuki
Van Lint, Maria Teresa
Kato, Seiko
Mohty, Mohamad
Forcade, Edouard
Kanamori, Heiwa
Sierra, Jorge
Ohno, Yuju
Saccardi, Riccardo
Fukuda, Takahiro
Ichinohe, Tatsuo
Takanashi, Minoko
Rocha, Vanderson
Okamoto, Shinichiro
Nagler, Arnon
Atsuta, Yoshiko
Gluckman, Eliane
Funding for this research was provided by:
Japan Agency for Medical Research and Development
Article History
Received: 26 January 2019
Revised: 28 May 2019
Accepted: 31 May 2019
First Online: 14 August 2019
Compliance with ethical standards
:
: JK reports honoraria from Chugai Pharmaceutical Co., Ltd., Celgene K.K., Otsuka Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Company Limited., Astellas Pharma Inc., Bristol-Myers Squibb, Sumitomo Dainippon Pharma Co., Ltd., Ono Pharmaceutical Co., Ltd., JCR Pharmaceuticals Co., Ltd., Pfizer Japan Inc., Kyowa Kirin, and MSD Pharma, outside the submitted work. GS reports grants, honoraria, advisory role, and travel accommodations expenses from Celgene, advisory role from Abbvie, Helsinn Healthcare, Janssen, Roche, Amgen, Boehringer Ingelheim, and Novartis, and travel accommodations expenses from Takeda and Gilead Sciences, outside the submitted work. EF reports grants from Neovii, outside the submitted work. SKako reports honoraria from Chugai Pharmaceutical Co., Ltd., Celgene K.K., Otsuka Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Company Limited., Astellas Pharma Inc., Bristol-Myers Squibb, Sumitomo Dainippon Pharma Co., Ltd., Ono Pharmaceutical Co., Ltd., JCR Pharmaceuticals Co., Ltd., and Pfizer Japan Inc., outside the submitted work. JS reports and Advisory and Speaker’s Bureau for Novartis, Pfizer, Celgene, Daiichi-Sankyo and Jazz Pharmaceuticals. SY reports grants from Kyowa Kirin, Astellas Pharma, Chugai Pharma, Mochida Pharma, Lilly Pharma, Takeda Pharma, MSD Pharma, Pfizer, Dai Nippon Sumitomo Pharma, and Ono Pharma, outside the submitted work.YA reports honoraria from CHUGAI PHARMACEUTICAL CO., LTD., Kyowa Kirin Co., Ltd, Bristol-Myers Squibb Co., Ltd, Yakult Honsha Co., Ltd., Janssen Pharmaceutical K.K., Otsuka Pharmaceutical Co., Ltd, and Mochida Pharmaceutical Co., Ltd, outside the submitted work. Other authors declare that they have no conflict of interest.